Logo for Pharmala Biotech Holdings Inc.
MDMA

Pharmala Biotech Holdings Inc.

Status
Active
Issued & Outstanding86,907,552
Reserved for Issuance6,040,000
Currency
CSE Index

About

Pharmala Biotech Holdings Inc.

Listing date
January 11, 2022
Social

Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of the Substituted methylenedioxy- phenethylamines class (“MDXX”), including 3,4-Methylenedioxymethamphetamine (“MDMA”). Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug delivery pathways for these molecules.